Abiopharma

OXFORD LANE CAPITAL CORP. (OXLCO)

Symbol	OXLCO
Name	OXFORD LANE CAPITAL CORP.
Sector	FINANCE
Region	North America
Industry	Investment Managers
Address	8 SOUND SHORE DRIVE,SUITE 255, GREENWICH, Connecticut, 06830, United States
Telephone	+1 203 983-5275
Fax	—
Email	—
Website	https://www.oxfordlanecapital.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001495222
Description	Oxford Lane Capital Corp is a non-diversified closed-end management investment company. The funds investment objective is to maximize its portfolios risk-adjusted total return over its investment horizon. Its current focus is to seek that return by investing in equity and junior tranches of CLO(collateralized loan obligation) vehicles, which are collateralized primarily by a diverse portfolio of senior loans, and which generally have little to no exposure to real estate loans, mortgage loans or pools of consumer-based debt, such as credit card receivables or auto loans. Its investment strategy also includes investing in warehouse facilities, which are financing structures intended to aggregate senior loans that may be used to form the basis of a CLO vehicle. Additional info from NASDAQ: Oxford Lane Capital Corp is a non-diversified closed-end management investment company. The funds investment objective is to maximize its portfolios risk-adjusted total return over its investment horizon. Its current focus is to seek that return by investing in equity and junior tranches of CLO(collateralized loan obligation) vehicles, which are collateralized primarily by a diverse portfolio of senior loans, and which generally have little to no exposure to real estate loans, mortgage loans or pools of consumer-based debt, such as credit card receivables or auto loans. Its investment strategy also includes investing in warehouse facilities, which are financing structures intended to aggregate senior loans that may be used to form the basis of a CLO vehicle.

2026-06-15 12:00

Oxford Lane Capital Corp. Provides May 2026 Net Asset Value Update

2026-06-08 18:21

New Form N-CEN - Oxford Lane Capital Corp. Filed: 2026-06-08 AccNo: 0000894189-26-017674 Size: 39 KB

2026-05-29 17:06

New Form 25-NSE - Oxford Lane Capital Corp. Filed: 2026-05-29 AccNo: 0001354457-26-000512 Size: 2 KB

2026-05-27 18:28

New Form NPORT-P - Oxford Lane Capital Corp. Filed: 2026-05-27 AccNo: 0000894189-26-016078 Size: 304 KB

2026-05-22 10:25

New Form N-CSR - Oxford Lane Capital Corp. Filed: 2026-05-22 AccNo: 0001213900-26-060338 Size: 18 MB

2026-05-08 21:59

New Form SCHEDULE 13D - Oxford Lane Capital Corp. Filed: 2026-05-08 AccNo: 0001104659-26-058142 Size: 19 KB

2026-05-04 17:20

New Form SCHEDULE 13G/A - Oxford Lane Capital Corp. Filed: 2026-05-04 AccNo: 0001104659-26-054922 Size: 11 KB

2026-04-27 12:00

Oxford Lane Capital Corp. Announces Full Redemption of 6.25% Series 2027 Term Preferred Stock

2026-04-24 17:06

New Form N-23C-2 - Oxford Lane Capital Corp. Filed: 2026-04-24 AccNo: 0001213900-26-047526 Size: 11 KB

2026-04-13 20:01

Correction: Oxford Lane Capital Corp. Announces Redemption of 2,800,000 Shares of 6.25% Series 2027 Term Preferred Stock